171 related articles for article (PubMed ID: 37424829)
1. Exploring the correlation of glycolysis-related chondroitin polymerizing factor (
Zhong Q; Jiang K; Zhang F; Tian Y; Gu J; Li T; Chen X; Yang J; Sun F
Am J Cancer Res; 2023; 13(6):2213-2233. PubMed ID: 37424829
[TBL] [Abstract][Full Text] [Related]
2. Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation.
Liu Z; Zhu F; Zhang P; Qian B; Liu W; Xiao Y; Chen N; He Q; Xiao J
Front Genet; 2022; 13():1074981. PubMed ID: 36506302
[No Abstract] [Full Text] [Related]
3. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
4. Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.
Zhang S; Yu S; Duan H; Xia W; Wang C; Shen H
Front Genet; 2022; 13():997573. PubMed ID: 36263417
[No Abstract] [Full Text] [Related]
5. A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma.
Zhou Z; Zhou Y; Liu W; Dai J
Front Genet; 2023; 14():1148430. PubMed ID: 37065485
[TBL] [Abstract][Full Text] [Related]
6. MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer.
Yun ZY; Wu D; Wang X; Huang P; Li N
Kaohsiung J Med Sci; 2024 Mar; 40(3):244-254. PubMed ID: 38190270
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L
FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643
[TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
Bai Y; Zhang Q; Liu F; Quan J
Front Immunol; 2022; 13():1027449. PubMed ID: 36451815
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer.
Song Q; Zhou R; Shu F; Fu W
Front Immunol; 2022; 13():958368. PubMed ID: 35990642
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma.
Qiu Y; Ye W; Wang C; Zang J
Aging (Albany NY); 2023 Nov; 15(22):13312-13328. PubMed ID: 38015710
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
Front Oncol; 2022; 12():856712. PubMed ID: 35372047
[TBL] [Abstract][Full Text] [Related]
12. Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer.
Zhou G; Li Y; Ren X; Qin G; Zhang Z; Zhao H; Gao L; Jiang X
Cancer Cell Int; 2023 Nov; 23(1):300. PubMed ID: 38017469
[TBL] [Abstract][Full Text] [Related]
13. Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma.
Che K; Han W; Li D; Cui S; Zhang M; Yang X; Niu H
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33558879
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.
Li H; Zu X; Hu J; Xiao Z; Cai Z; Gao N; Chen J
Front Immunol; 2022; 13():964393. PubMed ID: 36211344
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
Xu Q; Lin W; Tao C; Huang X; Li J
Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y
PeerJ; 2023; 11():e15284. PubMed ID: 37123010
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
[TBL] [Abstract][Full Text] [Related]
18. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression.
Du Y; Cao J; Jiang X; Cai X; Wang B; Wang Y; Wang X; Xue B
Cancer Cell Int; 2021 Nov; 21(1):613. PubMed ID: 34801033
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]